CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q2 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,970,000 | +84.4% | 57,500 | -11.5% | 0.03% | +116.7% |
Q2 2022 | $1,611,000 | +16.8% | 65,000 | +18.2% | 0.01% | -36.8% |
Q1 2022 | $1,379,000 | -42.4% | 55,000 | -60.7% | 0.02% | -40.6% |
Q3 2021 | $2,394,000 | +37.7% | 140,000 | +7.8% | 0.03% | +52.4% |
Q2 2021 | $1,739,000 | – | 129,900 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
Birchview Capital, LP | 25,000 | $428,000 | 0.29% |